GENELUX CORPORATION Earnings Per Share (Basic)
GENELUX CORPORATION (GNLX) reported Earnings Per Share (Basic) of -$0.21 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-13
- GENELUX CORPORATION earnings per share, basic for the quarter ending 2026-06-30 was -$0.21.
- GENELUX CORPORATION earnings per share, basic for the quarter ending 2026-03-31 was -$0.20.
- GENELUX CORPORATION earnings per share, basic for the quarter ending 2025-12-31 was -$0.24.
- GENELUX CORPORATION earnings per share, basic for the quarter ending 2025-09-30 was -$0.21.
- GENELUX CORPORATION earnings per share, basic for fiscal 2025 was -$0.86.
- GENELUX CORPORATION earnings per share, basic for fiscal 2024 was -$0.95.
- GENELUX CORPORATION earnings per share, basic for fiscal 2023 was -$1.16.
- GENELUX CORPORATION earnings per share, basic for fiscal 2022 was -$0.57.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.21 10-Q · filed 2026-08-13 | -$0.41 10-Q · filed 2026-08-13 | -$0.65 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.86 derived: net income ÷ weighted average shares · filed 2026-08-13 |
| 2026-03-31 | -$0.20 10-Q · filed 2026-05-07 | -$0.44 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.65 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.85 derived: net income ÷ weighted average shares · filed 2026-08-13 |
| 2025-12-31 | -$0.24 derived: net income ÷ weighted average shares · filed 2026-03-19 | -$0.45 derived: net income ÷ weighted average shares · filed 2026-03-19 | -$0.65 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.86 10-K · filed 2026-03-19 |
| 2025-09-30 | -$0.21 10-Q · filed 2025-11-05 | -$0.41 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.62 10-Q · filed 2025-11-05 | -$0.88 derived: net income ÷ weighted average shares · filed 2026-08-13 |
| 2025-06-30 | -$0.20 10-Q · filed 2026-08-13 | -$0.41 10-Q · filed 2026-08-13 | -$0.67 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.86 derived: net income ÷ weighted average shares · filed 2026-08-13 |
| 2025-03-31 | -$0.21 10-Q · filed 2026-05-07 | -$0.47 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.66 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.88 derived: net income ÷ weighted average shares · filed 2026-08-13 |
| 2024-12-31 | -$0.26 derived: net income ÷ weighted average shares · filed 2026-03-19 | -$0.45 derived: net income ÷ weighted average shares · filed 2026-03-19 | -$0.67 derived: net income ÷ weighted average shares · filed 2026-03-19 | -$0.95 10-K · filed 2026-03-19 |
| 2024-09-30 | -$0.19 10-Q · filed 2025-11-05 | -$0.41 derived: net income ÷ weighted average shares · filed 2025-11-05 | -$0.69 10-Q · filed 2025-11-05 | -$0.76 derived: net income ÷ weighted average shares · filed 2026-03-19 |
| 2024-06-30 | -$0.22 10-Q · filed 2025-08-07 | -$0.51 10-Q · filed 2025-08-07 | -$0.57 derived: net income ÷ weighted average shares · filed 2026-03-19 | -$0.77 derived: net income ÷ weighted average shares · filed 2026-03-19 |
| 2024-03-31 | -$0.29 10-Q · filed 2025-05-06 | -$0.36 derived: net income ÷ weighted average shares · filed 2026-03-19 | -$0.55 derived: net income ÷ weighted average shares · filed 2026-03-19 | -$0.78 derived: net income ÷ weighted average shares · filed 2026-03-19 |
| 2023-12-31 | -$0.12 derived: net income ÷ weighted average shares · filed 2026-03-19 | -$0.30 derived: net income ÷ weighted average shares · filed 2026-03-19 | -$0.51 derived: net income ÷ weighted average shares · filed 2026-03-19 | -$1.16 10-K · filed 2025-03-28 |
| 2023-09-30 | -$0.20 10-Q · filed 2024-11-14 | -$0.44 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$0.91 10-Q · filed 2024-11-14 | -$1.25 derived: net income ÷ weighted average shares · filed 2024-11-14 |
| 2023-06-30 | -$0.23 10-Q · filed 2024-08-14 | -$0.72 10-Q · filed 2024-08-14 | -$1.10 derived: net income ÷ weighted average shares · filed 2024-08-14 | -$0.94 derived: net income ÷ weighted average shares · filed 2024-08-14 |
| 2023-03-31 | -$0.53 10-Q · filed 2024-05-09 | -$0.97 derived: net income ÷ weighted average shares · filed 2024-05-09 | -$0.71 derived: net income ÷ weighted average shares · filed 2024-05-09 | -$1.00 derived: net income ÷ weighted average shares · filed 2024-05-09 |
| 2022-12-31 | -$0.38 derived: net income ÷ weighted average shares · filed 2024-03-29 | $0.16 derived: net income ÷ weighted average shares · filed 2024-03-29 | -$0.15 derived: net income ÷ weighted average shares · filed 2024-03-29 | -$0.57 10-K · filed 2024-03-29 |
| 2022-09-30 | $0.54 10-Q · filed 2023-11-14 | $0.23 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$0.19 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $0.31 10-Q · filed 2023-08-14 | -$0.73 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | -$0.42 10-Q · filed 2023-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |